| 产品描述: | Ras抑制剂;Ras Inhibitors;;InformationBQU57 BQU57, a derivative of RBC8, is a selective GTPase Ral inhibitor relative to the GTPases Ras and RhoA.TargetsGTPase RalIn vitroIn both the H2122 and H358 cell lines, BQU57 inhibits both RalA and RalB activation, and thus causes cell growth inhibition.In vivoIn mice bearing human lung H2122 tumors, BQU57 (50 mg/kg, i.p.) significantly inhibits activation of both RalA and RalB, and causes dose-dependent tumor growth inhibition.Cell Research(from reference)Cell lines:Human lung cancer lines, H2122, H358, H460 and Calu6 Concentrations:~10 μM Incubation Time:48 hours |
| 体内研究: |
BQU57 (1 mg/kg 和 5 mg/kg;ip;每日 1 次;6 周) 显著缓解大鼠腰椎不稳诱导的椎间盘退变,减少髓核细胞凋亡并维持椎间盘结构完整性。 BQU57 (50 mg/kg;ip;每周 3 次;21 天) 显著抑制三阴性乳腺癌 (TNBC) 小鼠原位肿瘤生长及肺转移,延长生存期。 |
| 参考文献: |
1. Yan C, et al. Discovery and characterization of small molecules that target the GTPase Ral. Nature. 2014 Nov 20;515(7527):443-447. 2. Qiu X, et al. BQU57 suppresses IL-1β-induced apoptosis and extracellular matrix degradation in nucleus pulposus cells by blocking the NF-κB signaling pathway. Cell Signal. 2025 Mar 8:111729. 3. Thies KA, et al. The small G-protein RalA promotes progression and metastasis of triple-negative breast cancer. Breast Cancer Res. 2021 Jun 12;23(1):65. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.993 ml |
14.966 ml |
29.931 ml |
| 5 mM |
0.599 ml |
2.993 ml |
5.986 ml |
| 10 mM |
0.299 ml |
1.497 ml |
2.993 ml |
| 50 mM |
0.06 ml |
0.299 ml |
0.599 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |